A detailed history of Morgan Stanley transactions in Atrion Corp stock. As of the latest transaction made, Morgan Stanley holds 60,633 shares of ATRI stock, worth $27.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,633
Previous 5,968 915.97%
Holding current value
$27.4 Million
Previous $2.26 Million 1143.63%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$308.3 - $463.55 $16.9 Million - $25.3 Million
54,665 Added 915.97%
60,633 $28.1 Million
Q4 2023

Feb 13, 2024

BUY
$289.29 - $409.7 $710,206 - $1.01 Million
2,455 Added 69.88%
5,968 $2.26 Million
Q3 2023

Nov 15, 2023

SELL
$401.2 - $581.79 $655,962 - $951,226
-1,635 Reduced 31.76%
3,513 $1.45 Million
Q2 2023

Aug 14, 2023

BUY
$500.0 - $659.0 $510,500 - $672,839
1,021 Added 24.74%
5,148 $2.91 Million
Q1 2023

May 15, 2023

BUY
$565.0 - $694.87 $290,410 - $357,163
514 Added 14.23%
4,127 $2.59 Million
Q4 2022

Feb 14, 2023

SELL
$551.1 - $688.5 $129,508 - $161,797
-235 Reduced 6.11%
3,613 $2.02 Million
Q3 2022

Nov 14, 2022

BUY
$545.43 - $680.3 $113,994 - $142,182
209 Added 5.74%
3,848 $2.17 Million
Q2 2022

Oct 27, 2022

BUY
$605.0 - $763.25 $1.14 Million - $1.44 Million
1,884 Added 107.35%
3,639 $2.29 Million
Q2 2022

Aug 15, 2022

BUY
$605.0 - $763.25 $1.14 Million - $1.44 Million
1,884 Added 107.35%
3,639 $2.29 Million
Q1 2022

Oct 27, 2022

SELL
$601.4 - $763.0 $1.13 Million - $1.44 Million
-1,884 Reduced 51.77%
1,755 $1.25 Million
Q1 2022

May 13, 2022

BUY
$601.4 - $763.0 $43,300 - $54,936
72 Added 4.28%
1,755 $1.25 Million
Q4 2021

Feb 14, 2022

BUY
$650.15 - $802.0 $213,249 - $263,056
328 Added 24.21%
1,683 $1.19 Million
Q3 2021

Nov 15, 2021

BUY
$594.24 - $758.0 $805,195 - $1.03 Million
1,355 New
1,355 $944,000

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Market Cap $808M
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.